Alnylam Gets Some Welcome News

newsfeedback@fool.com (Todd Campbell), The Motley Fool
Fri, 12/15/2017 - 1:00pm

The FDA has agreed to allow Alnylam (NASDAQ: ALNY) and Sanofi (NYSE: SNY) to resume trials of their hemophilia therapy, fitusiran. Previously, these companies had to halt their fitusiran studies after a patient who had advanced into an extension study died because of a fatal blood clot. Is this news good for patients and investors?Hemophilia A is caused by a deficiency of blood coagulation factor VIII and hemophilia B is caused by a deficiency of blood coagulation factor IX.

NEXT
Topics:  fda   alnylam nasdaq   alny    sanofi nyse   sny    hemophilia a   viii   ix in   images   a   news   blood   deficiency   
BING SEARCH:
  • Alnylam Pharmaceuticals
    Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
    04/22/2024 - 11:37 am | View Website
  • Alnylam® Pharmaceuticals
    THE LEADING RNAi THERAPEUTICS COMPANY. Alnylam has led the translation of RNA interference (RNAi) from Nobel Prize-winning discovery into an entirely new class of medicines, which we believe has the potential to help people all over the world to live longer, healthier, and fuller lives.
    04/22/2024 - 1:07 am | View Website
  • ALNY | Alnylam Pharmaceuticals Inc. Profile | MarketWatch
    Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
    04/21/2024 - 3:56 pm | View Website
  • Alnylam Pharmaceuticals Press Release | Apr 18, 2024 | Alnylam to ...
    Alnylam has a deep pipeline of investigational medicines, including multiple product candidates that are in late-stage development. Alnylam is executing on its “Alnylam P 5 x25” strategy to deliver transformative medicines in both rare and common diseases benefiting patients around the world through sustainable innovation and exceptional ...
    04/21/2024 - 4:29 am | View Website
  • About Alnylam® Pharmaceuticals
    We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
    04/20/2024 - 2:14 am | View Website
  • More
NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News

  • Sustainable laptops to make every day Earth Day
    Mashable, Tuesday - 04/23/2024 - 04:33 PM

    We all want to make greener choices, but shopping for sustainable tech products isn’t quite as easy as choosing greener fashion or furniture, partly because high-performance second-hand tech is almost impossible to come by. Dell and Intel have set out to change that with their Advancing Sustainability action plan, which aims to drive sustainability across the entire product lifecycle.

    More | Talk | Read It Later | Share
  • New FTC Rule Bans ‘Noncompete’ Agreements for Most Employees
    Time, Tuesday - 04/23/2024 - 04:11 PM

    (WASHINGTON, D. C.) — U. S. companies would no longer be able to bar employees from taking jobs with competitors under a rule approved by a federal agency Tuesday, though the rule is sure to be challenged in court. The Federal Trade Commission voted Tuesday 3-2 to ban measures known as noncompete agreements, which bar workers from jumping to or starting competing companies for a prescribed period of time.

    More | Talk | Read It Later | Share
  • A TikTok ban would probably also take down CapCut, Lemon8, and more
    Mashable, Tuesday - 04/23/2024 - 03:58 PM

    The U. S. government is inching closer and closer to a TikTok ban, a move that would impact more than just TikTok. As Mashable reported over the weekend, the House passed an updated version of the ban with bipartisan support. If or when it makes its way to President Biden's desk, Biden has signaled he will sign it into law, and effectively ban TikTok in the U.

    More | Talk | Read It Later | Share
  • Adobe unveils AI features for Photoshop — but not everyone is happy about it
    Mashable, Tuesday - 04/23/2024 - 03:16 PM

    Adobe has new generative AI features for rookie Photoshop users, but there are concerns from creative professionals. On Tuesday, Adobe announced a beta version of Photoshop with new features to generate and edit images from text prompts. Generative AI capabilities are powered by Adobe's Firefly Image 3 model which was also released today.

    More | Talk | Read It Later | Share
  • The case for Tesla without Musk
    Mashable, Tuesday - 04/23/2024 - 02:40 PM

    Pop quiz, Tesla fans. Who at the EV automaker made this memorable assessment of the company's latest product: "we have dug our own grave with the Cybertruck"? Was it some cowardly VP who doesn't believe in Dear Leader's glorious vision? Perhaps Drew Baglino or Rohan Patel, two top execs who joined the ten percent of Tesla employees getting pink slips this week?

    More | Talk | Read It Later | Share
  • Rumored new 4K Chromecast may fix long-standing storage issues
    Ars Technica, Tuesday - 04/23/2024 - 01:43 PM

    Enlarge / The 2020 4K Chromecast with Google TV. It comes in colors. (credit: Google) It sounds like Google is cooking up another Google TV dongle. 9to5Google's sources say a new 4K model of the Chromecast with Google TV is in the works. It would be a sequel to the aging 2020 model that was never really fit for the job in the first place.

    More | Talk | Read It Later | Share